Peter Blume-Jensen

All filings by Peter Blume-Jensen on record concern Acrivon Therapeutics, Inc. The record holds 26 filings, for trades running from 14 November 2022 to 25 August 2026.

On the open market, the record shows 1 purchase worth €71k and 3 sales worth €30k. The net balance comes to €41k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 21 share grants and 1 option exercise. Since January 2026: 1 purchase and 3 sales on the market.

The record was last updated on 27 August 2026 with an open-market sale (€27k) in Acrivon Therapeutics, Inc. The most recent open-market purchase was published on 16 January 2026, 275 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.